 |
|
|
|
|
|
|
|
|
|
|
Wednesday May 12th
|
|
|
|
|
|
|
|
|
|
|
05:30 pm
|
|
|
CONGRESS OPENING CEREMONY
|
|
|
06:00 pm
|
|
|
Opening Lecture
Chair: Fruchart J.-C. (France)
Metabolic syndrome ? From new epidemiology to new definition: who is the violin in the quartet ?
Shlyakhto Evgeny (Russia)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thursday May 13th
|
|
Friday May 14th
|
|
Saturday May 15th
|
|
M
O
R
N
I
N
G
|
|
|
|
|
|
|
|
|
08:30 am / 10:00 am
|
|
08:30 am / 10:30 am
|
|
09:00 am / 10:30 am
|
|
|
|
|
|
|
|
|
|
ACADEMIC SESSION I
Metabolic disorders:
global risks, diagnosis and management
Chair: Brewer B. (USA)
Odawara M. (Japan)
Amarenco P. (France)
Ogawa H. (Japan)
|
|
R3i Symposium
Lipid-related residual vascular risk.
Opening the new era of vascular prevention
Fruchart J.-C. (France)
Sacks F. (USA)
Hermans M. (Belgium)
Ginsberg H. (USA)
|
|
ACADEMIC SESSION V
Metabolic and genetic biomarkers
Chair: Carmena R. (Spain)
Davignon J. (Canada)
Koenig W. (Germany)
Froguel P. (France)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:00 am / 10:45 am
|
|
|
|
|
|
|
|
|
|
|
|
State of the Art Lecture
Chair: Fruchart J.-C. (France)
Al-Rubeaan K. (Saudi Arabia)
|
|
|
|
|
10:45 / 11:15 am
Coffee break
|
|
10:30 am / 11:00 am
Coffee break
|
|
10:30 am / 11:00 am
Coffee break
|
|
|
11:15 am / 12:45 pm
|
|
11:00 am / 12:30 pm
|
|
11:00 am / 12:30 pm
|
|
|
|
|
|
|
|
|
|
Symposium sponsored by
SOLVAY PHARMACEUTICALS
The unfinished business in
vascular risk reduction
Chair: Fruchart J.-C. (France)
Fruchart J.-C. (France)
Elam M. (USA)
O'Brien R. (Australia)
Bersot T. (USA)
|
|
Symposium sponsored by KOWA
Future therapeutic approaches
for atherosclerosis
Potential and application of
novel statin
Chair: Kita T. (Japan)
Matsuzawa Y. (Japan)
Corsini A. (Italy)
Egashira K. (Japan)
|
|
ACADEMIC SESSION VI
No traditional risk factors of cardiometabolic disease
Chair: Sadikot S.M. (India)
Ahmed Q. (USA)
Guzik T. (Poland)
Rouis M. (France)
|
|
|
|
12:45 pm / 02:00 pm
Lunch
|
|
12:30 pm / 02:00 pm
Lunch
|
|
12:30 pm / 02:00 pm
Lunch
|
|
|
|
|
|
|
|
|
|
A
F
T
E
R
N
O
O
N
|
|
02:00 pm / 03:30 pm
|
|
02:00 pm / 03:30 pm
|
|
02:00 pm / 03:00 pm
|
|
|
|
|
|
|
|
|
|
FONDATION CŒUR ET ARTERES
Symposium
Statins and fibrates in CHD prevention:
where are we now ?
Chair: Greten H. (Germany)
Assmann G. (Germany)
Packard C. (UK)
Zambon A. (Italy)
Valensi P. (France)
|
|
ACADEMIC SESSION III
Lifestyle and exercise versus medical therapies in prevention and management of the metabolic syndrome
Chair: Sacks F. (USA)
Farinaro E. (Italy)
Kodama T. (Japan)
Carmena R. (Spain)
|
|
ORAL COMMUNICATIONS
SELECTED FROM ABSTRACTS
Chair: Rouis M. (France)
|
|
|
03:30 pm / 04:00 pm
Coffee break
|
|
03:30 pm / 04:00 pm
Coffee break
|
|
03:00 pm / 03:30 pm
Coffee break
|
|
|
04:00 pm / 05:30 pm
|
|
04:00 pm / 05:30 pm
|
|
03:30 pm / 05:30 pm
|
|
|
|
|
|
|
|
|
|
ACADEMIC SESSION II
New targets in drug development
Chair: Hermans M. (Belgium)
Krempf M. (France)
Gupta S. (UK)
Duriez P. (France)
|
|
ACADEMIC SESSION IV
Metabolic dyslipoproteinemia and atherosclerosis
Chair: Davignon J. (Canada)
Sadikot S. M. (India)
Ceska R. (Czek Republic)
Brewer B. (USA)
|
|
POSTER SESSION
Chair: Fruchart J.-C.(France)
END OF THE CONGRESS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
